Skip to Content
Merck

Key Documents

View All Documentation

Skip To

909335

Sigma-Aldrich

2-(2,4-Difluorophenyl)-5-(trifluoromethyl)pyridine

≥95%

Synonym(s):

dFCF3ppy

Sign Into View Organizational & Contract Pricing

About This Item

Empirical Formula (Hill Notation):
C12H6F5N
CAS Number:
387827-64-7
Molecular Weight:
259.17
MDL number:
MFCD28144542
UNSPSC Code:
12352101
NACRES:
NA.22
Pricing and availability is not currently available.
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Assay

≥95%

form

powder or crystals

reaction suitability

reaction type: Photocatalysis
reagent type: catalyst

mp

59-64 °C

SMILES string

FC(F)(F)c1cnc(cc1)c2c(cc(cc2)F)F

InChI

1S/C12H6F5N/c13-8-2-3-9(10(14)5-8)11-4-1-7(6-18-11)12(15,16)17/h1-6H

InChI key

FMKQPMDFNYNYAG-UHFFFAOYSA-N

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
908762902810908177
2-(2,4-Difluorophenyl)-5-(trifluoromethyl)pyridine ≥95%

909335

2-(2,4-Difluorophenyl)-5-(trifluoromethyl)pyridine

5,5′-Bis(trifluoromethyl)-2,2′-bipyridine ≥95%

908762

5,5′-Bis(trifluoromethyl)-2,2′-bipyridine

4,4′-Bis(trifluoromethyl)-2,⋅2′-bipyridine

902810

4,4′-Bis(trifluoromethyl)-2,⋅2′-bipyridine

3DPAFIPN ≥95%

908177

3DPAFIPN

assay

≥95%

assay

≥95%

assay

≥95%

assay

≥95%

reaction suitability

reaction type: Photocatalysis, reagent type: catalyst

reaction suitability

reaction type: Photocatalysis, reagent type: catalyst

reaction suitability

-

reaction suitability

reaction type: Photocatalysis, reagent type: catalyst

form

powder or crystals

form

powder or crystals

form

solid

form

powder

mp

59-64 °C

mp

129-130 °C

mp

78-80 °C

mp

307-401 °C

Application

2-(2,4-Difluorophenyl)-5-(trifluoromethyl)pyridine is a ligand used for the preparation of Ir(III) photocatalysts.

Product can be used with our line of photoreactors: Including Penn PhD (Z744035) & SynLED 2.0 (Z744080)

Other Notes

Single-electron transmetalation in organoboron cross-coupling by photoredox/nickel dual catalysis

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

  • Specification Sheet

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

    If you need assistance, please contact Customer Support

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    S Yamashiro et al.
    Acta neurochirurgica, 139(10), 987-990 (1997-01-01)
    This 67 year-old man experienced 3 episodes of symptomatic hyponatraemia. Radiological examination revealed a sellar lesion and the tumour was removed via the transsphenoidal route. Thereafter, he simultaneously developed intractable diabetes insipidus and serious hyponatraemia with persistent natriuresis. His level
    Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    Annane D, et al.
    JAMA : The Journal of the American Medical Association, 288(7), 862-871 (2002)
    Dong-Min Kim et al.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22(11), 3273-3276 (2007-07-10)
    Hyperkalaemia is a commonly encountered problem in dialysis patients with end-stage renal disease (ESRD). The aim of the present study was to assess the effect of fludrocortisone acetate (FCA) on reducing serum potassium levels in haemodialysis (HD) patients with hyperkalaemia.
    Clinical Pharmacology Made Incredibly Easy! (2009)
    R Taniguchi et al.
    The Tohoku journal of experimental medicine, 186(3), 215-223 (1999-05-29)
    It is known that some patients with primary aldosteronism show postoperative hyperkalemia, which is due to inability of the adrenal gland to secrete sufficient amounts of aldosterone. However, hyperkalemia is generally neither severe nor prolonged, in which replacement therapy with
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service